» Articles » PMID: 21922857

Serum IL-6 and IL-8 in Infants with Biliary Atresia in Comparison to Intrahepatic Cholestasis

Overview
Specialty Gastroenterology
Date 2011 Sep 20
PMID 21922857
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Biliary atresia (BA) is an idiopathic progressive inflammation and fibrosclerosis of the extra and intrahepatic bile ducts.

Aim: To measure the serum levels of IL-6 and IL-8 in biliary atresia and correlate with clinical outcome.

Methods: Sixty children were included, 20 with BA (group 1), 20 with intrahepatic cholestasis (group 2) and 20 normal children as controls. Complete blood count (CBC), liver function tests, serum IL-6 and IL-8 were analyzed in all the three groups.

Results: Mean serum IL-6 and IL-8 levels were significantly higher in group 1 (394.7 +/- 40.2 and 111.2 +/- 9.7 pg/dl, respectively) than group 2 (175.5 +/- 33.1 and 53.5 +/- 8.2 pg/dl, respectively) (p=0.0 for both). Both IL-6 and IL-8 were significantly higher in both the disease groups compared to controls (30.4 +/- 8.8 and 13.7 +/- 4.1 pg/dl, respectively). IL-8 showed a significant positive correlation with lymphocytes and significant negative correlation with albumin in group 1. Higher IL-6 was found in patients with BA with severe fibrosis than in patients with mild fibrosis while higher IL-8 was found in children with persistent jaundice than those free from jaundice in group 1.

Conclusion: Serum IL-6 and IL8 are high in patients with BA indicating ongoing inflammation. They may serve to determine disease severity and may predict the progression to liver fibrosis in these cases.

Citing Articles

Mitochondria at the Crossroads of Cholestatic Liver Injury: Targeting Novel Therapeutic Avenues.

Li X, Ruan T, Wang S, Sun X, Liu C, Peng Y J Clin Transl Hepatol. 2024; 12(9):792-801.

PMID: 39280065 PMC: 11393838. DOI: 10.14218/JCTH.2024.00087.


Progress in Biomarkers Related to Biliary Atresia.

Kong F, Dong R, Chen G, Sun S, Yang Y, Jiang J J Clin Transl Hepatol. 2024; 12(3):305-315.

PMID: 38426193 PMC: 10899875. DOI: 10.14218/JCTH.2023.00260.


Immune-mediated cholangiopathies in children: the need to better understand the pathophysiology for finding the future possible treatment targets.

Grama A, Mititelu A, Sirbe C, Benta G, Pop T Front Immunol. 2023; 14:1206025.

PMID: 37928553 PMC: 10623351. DOI: 10.3389/fimmu.2023.1206025.


Potential therapeutic target of EGF on bile duct ligation model and biliary atresia children.

Zheng Q, Li M, Chen L, Zhang C, Zhao Y, Liu G Pediatr Res. 2023; 94(4):1297-1307.

PMID: 37138025 DOI: 10.1038/s41390-023-02592-4.


Relationship between the expression levels of CD4+ T cells, IL-6, IL-8 and IL-33 in the liver of biliary atresia and postoperative cholangitis, operative age and early jaundice clearance.

Zhang K, Chen Y, Zheng Z, Tang C, Zhu D, Xia X Pediatr Surg Int. 2022; 38(12):1939-1947.

PMID: 36242601 DOI: 10.1007/s00383-022-05258-0.